← Back to Clinical Trials
Recruiting NCT07560397

NCT07560397 Feasibility Study on the Implementation of a Supervised, Home-based Adapted Physical Activity Program for Patients With Head and Neck Cancer

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07560397
Status Recruiting
Phase
Sponsor Centre Henri Becquerel
Condition Head & Neck Cancer
Study Type INTERVENTIONAL
Enrollment 66 participants
Start Date 2026-07-22
Primary Completion 2028-06-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
physical activity program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 66 participants in total. It began in 2026-07-22 with a primary completion date of 2028-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Head and neck cancers are the seventh most common type of cancer worldwide. The standard of care is surgical removal of the tumor, often accompanied by simultaneous reconstruction of the affected structures. Enhanced post-surgical rehabilitation programs are offered to promote early recovery of functional abilities; they are applicable to all patients and all surgical specialties. Studies have shown a very significant benefit of physical activity prior to surgery in the context of cancers of the digestive or thoracic systems. Multimodal programs that incorporate nutritional and psychosocial factors and include physical exercise have been shown to improve postoperative mobility and physical activity levels in patients with colorectal, gastrointestinal, lung, and prostate cancers. Our hypothesis is based on the premise that implementing an exercise program during the preoperative period could promote a return to optimal functional capacity, reduce the incidence of postoperative pulmonary complications, and lower overall morbidity. Furthermore, we believe that the proposed support would encourage greater patient involvement in their care journey starting in the preoperative period and raise their awareness of the importance of postoperative mobilization. Early patient involvement would thus help develop their sense of self-efficacy and promote behavioral change toward a more active lifestyle suited to their health status. Consequently, maintaining physical activity after surgery and in the post-cancer period-recognized as a factor in secondary and tertiary prevention-would be encouraged.

Eligibility Criteria

Inclusion Criteria: * surgery requiring the placement of a covering flap) * Medical prescription of adapted physical activity * A period of more than 2 weeks between the announcement of surgery and the surgery itself Exclusion Criteria: * Absolute contraindications to physical activity * Pregnant or breastfeeding women * Patients who, for any reason, are unable to understand the study or comply with the trial requirements (language, psychological, or geographical barriers, etc.)

Contact & Investigator

Central Contact

Elise Carpentier

✉ elise.carpentier@chb.unicancer.fr

📞 +33232082985

Principal Investigator

Elise Carpentier

PRINCIPAL INVESTIGATOR

Centre Henri Becquerel

Frequently Asked Questions

Who can join the NCT07560397 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Head & Neck Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07560397 currently recruiting?

Yes, NCT07560397 is actively recruiting participants. Contact the research team at elise.carpentier@chb.unicancer.fr for enrollment information.

Where is the NCT07560397 trial being conducted?

This trial is being conducted at Rouen, France.

Who is sponsoring the NCT07560397 clinical trial?

NCT07560397 is sponsored by Centre Henri Becquerel. The principal investigator is Elise Carpentier at Centre Henri Becquerel. The trial plans to enroll 66 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology